Cytek Biosciences, Inc.
CTKB
$3.77
-$0.05-1.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.89% | -3.56% | -7.24% | -9.67% | -23.08% |
| Total Receivables | 7.96% | -8.64% | -14.10% | 11.66% | 10.31% |
| Inventory | -28.06% | -30.52% | -24.33% | -21.47% | 25.41% |
| Prepaid Expenses | 16.30% | -13.55% | -9.18% | 3.07% | -10.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.68% | 74.59% | 101.47% | 21.88% | -4.57% |
| Total Current Assets | 1.12% | -7.61% | -9.59% | -8.69% | -13.65% |
|
|
|||||
| Total Current Assets | 1.12% | -7.61% | -9.59% | -8.69% | -13.65% |
| Net Property, Plant & Equipment | -3.86% | -1.67% | -2.03% | -1.88% | 6.14% |
| Long-term Investments | 2.97% | -1.66% | -15.46% | -15.46% | 59.53% |
| Goodwill | 2.97% | -1.66% | -15.46% | -15.46% | 59.53% |
| Total Other Intangibles | -12.81% | -15.64% | -9.56% | -9.78% | 432.99% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.86% | 33.06% | 24.46% | 41.83% | 44.65% |
| Total Assets | 1.02% | -5.43% | -7.87% | -6.20% | -4.82% |
|
|
|||||
| Total Accounts Payable | 82.35% | 14.39% | 3.54% | -29.45% | -36.90% |
| Total Accrued Expenses | 14.20% | 0.88% | -23.27% | -13.53% | -6.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.44% | 61.25% | 24.08% | -21.39% | -14.30% |
| Total Finance Division Other Current Liabilities | 2.69% | 3.76% | 7.77% | 9.28% | 53.63% |
| Total Other Current Liabilities | 2.69% | 3.76% | 7.77% | 9.28% | 53.63% |
| Total Current Liabilities | 20.34% | 6.99% | -2.26% | -1.68% | 14.65% |
|
|
|||||
| Total Current Liabilities | 20.34% | 6.99% | -2.26% | -1.68% | 14.65% |
| Long-Term Debt | -36.29% | -28.80% | -29.33% | -30.75% | -27.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.33% | -23.50% | -25.11% | -24.64% | -23.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.22% | 1.91% | -5.18% | 9.02% | 12.32% |
| Total Liabilities | 2.34% | 1.79% | -6.22% | -1.64% | 7.95% |
|
|
|||||
| Common Stock & APIC | 1.75% | -4.78% | -4.20% | -4.10% | -4.40% |
| Retained Earnings | -20.64% | -29.29% | -62.20% | -48.29% | -71.33% |
| Treasury Stock & Other | 101.25% | 106.40% | 88.91% | -164.74% | -82.93% |
| Total Common Equity | 0.68% | -7.23% | -8.26% | -7.28% | -7.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.68% | -7.23% | -8.26% | -7.28% | -7.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.68% | -7.23% | -8.26% | -7.28% | -7.63% |
|
|
|||||